CAJ | 학술논문

目的探讨2001-2010年中国麻风病流行病学特征.方法收集2001-2010年全国麻风病流行病学资料,开展描述和比较性分析.结果 2001-2010年共新发现麻风病例15 507例,年平均发现率为0.118/10万,其中儿童占2.7％、多菌型占86.5％、2级畸残占22.5％.2001-2010年共发现复发病例1 506例,其中464例为联合化疗后复发.高流行区与低流行区相比,新发现麻风病例中的儿童患者、女性患者、流动人口患者和复发病例中的联合化疗后复发病例,差异有统计学意义.至2010年底全国尚有现症病例6032例,患病率为0.450/10万,其中2886例在接受联合化疗.结论 2001-2010年全国麻风病发现率继续下降,但分布不均衡,麻风病高流行省份为云南、贵州、四川、广东、湖南、西藏.建议进一步加强麻风病管理、降低麻风病患者畸残.
목적 탐토2001-2010년중국마풍병류행병학특정.방법 수집2001-2010년전국마풍병류행병학자료,개전묘술화비교성분석.결과 2001-2010년공신발현마풍병례15 507례,년평균발현솔위0.118/10만,기중인동점2.7％、다균형점86.5％、2급기잔점22.5％.2001-2010년공발현복발병례1 506례,기중464례위연합화료후복발.고류행구여저류행구상비,신발현마풍병례중적인동환자、녀성환자、류동인구환자화복발병례중적연합화료후복발병례,차이유통계학의의.지2010년저전국상유현증병례6032례,환병솔위0.450/10만,기중2886례재접수연합화료.결론 2001-2010년전국마풍병발현솔계속하강,단분포불균형,마풍병고류행성빈위운남、귀주、사천、엄동、호남、서장.건의진일보가강마풍병관리、강저마풍병환자기잔.
Objective To study the epidemiological characteristics of leprosy in China,2001-2010.Methods Data were collected from the database of the national system of leprosy surveillance.A descriptive and comparative analysis was performed.Results Totally,15 507 new leprosy cases were detected from 2001 to 2010 with an average case detection rate of 0.118 per 100 000 population.Among these cases,2.7％ were children under 15 years,86.5％ multibacillary,and 22.5％ suffered from grade 2 disability.From 2001 to 2010,a total of 1506 relapse cases were detected,and relapse occurred after multi-drug therapy (MDT) in 464 of these cases.There were significant differences between low and high endemic areas in the proportion of children under 15 years,females,immigrant patients among newly detected patients as well as the proportion of cases of relapse after MDT among all the relapse cases.By the end of 2010,the registered leprosy cases were 6032 with a prevalence rate of 0.450 per 100 000 population,among whom 2886 were under MDT.Conclusions The leprosy case detection rate continued to decrease in China from 2001 to 2010 with an unequal distribution.The pocket areas were in Yunnan province,Guizhou province,Sichuan province,Guangdong province,Hunan province and Tibet Autonomous Region.It is warranted to enhance the control of leprosy and reduce the prevalence of disability due to leprosy.